CRESCENT BIOPHARMA, INC. Defined Contribution Plan, Employer Matching Contribution, Percent of Match
CRESCENT BIOPHARMA, INC. (CBIO) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Match of 50.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch · last filed 2025-02-13
- CRESCENT BIOPHARMA, INC. defined contribution plan, employer matching contribution, percent of match for fiscal 2024 was 50.00%, a 0.00% change from fiscal 2023.
- CRESCENT BIOPHARMA, INC. defined contribution plan, employer matching contribution, percent of match for fiscal 2023 was 50.00%, a 0.00% change from fiscal 2022.
- CRESCENT BIOPHARMA, INC. defined contribution plan, employer matching contribution, percent of match for fiscal 2022 was 50.00%, a 0.00% change from fiscal 2021.
- CRESCENT BIOPHARMA, INC. defined contribution plan, employer matching contribution, percent of match for fiscal 2021 was 50.00%, a 0.00% change from fiscal 2020.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 12 month |
|---|---|
| 2024-12-31 | 50.00% 10-K · filed 2025-02-13 |
| 2023-12-31 | 50.00% 10-K · filed 2025-02-13 |
| 2022-12-31 | 50.00% 10-K · filed 2025-02-13 |
| 2021-12-31 | 50.00% 10-K · filed 2024-03-27 |
| 2020-12-31 | 50.00% 10-K · filed 2023-03-29 |
| 2019-12-31 | 50.00% 10-K · filed 2022-03-03 |
| 2018-12-31 | 50.00% 10-K · filed 2021-03-02 |
| 2017-12-31 | 50.00% 10-K · filed 2020-02-28 |
| 2016-12-31 | 50.00% 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |